CBP 200
Generic Name: cefditoren
Pill imprint CBP 200 has been identified as Spectracef 200 mg.
Spectracef is used in the treatment of skin infection; bronchitis; pneumonia; tonsillitis/pharyngitis; skin and structure infection and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy.
Spectracef 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Spectracef Images
- Generic Name:
- cefditoren
- Imprint:
-
CBP 200
- Strength:
- 200 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- carnauba wax
croscarmellose sodium
D&C Red No. 27
mannitol
hydroxypropyl cellulose
hypromelloses
magnesium stearate
polyethylene glycol
propylene glycol
shellac
sodium caseinate
sodium tripolyphosphate
titanium dioxide
FD&C Blue No. 1
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cornerstone BioPharma Inc
- National Drug Code (NDC):
- 10122-0801
Advertisement
More Spectracef resources
- Spectracef (Wolters Kluwer)
- Spectracef (Cerner Multum)
- Spectracef (Micromedex) - Includes Dosage Information
- Spectracef (AHFS DI)
- Spectracef (FDA)
Search Again
